Compounding Pharmacy Oversight Under Fire by Senate Committee

Share on Facebook
Last week, a Senate committee questioned states on the oversight of compounding pharmacies as part of its investigation into the fungal meningitis outbreak linked to products from the New England Compounding Center in Framingham, Mass., according to an AHA News Now report.

The outbreak is tied to injectable epidural steroid medication that was later recalled by NECC. The medication has caused 33 deaths and more than 480 illnesses so far, according to a Senate report.

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!

The Senate Health, Education, Labor and Pensions Committee asked state boards of pharmacy several questions related to compounding pharmacies. The committee also asked the boards to provide their requirements for compounding pharmacies and physicians, as well as any previous complaints or disciplinary actions against NECC in their state, by Dec. 7.

More Articles on the Meningitis Outbreak:

"Bureaucratic Inertia" to Blame in NECC's Continued Operation, Senate Committee Says
House Hears Testimony on Meningitis Outbreak

CDC Launches Consultation Services for Clinicians Treating Fungal Meningitis Cases

© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

New From Becker's Infection Control & Clinical Quality

Most-missed handwashing spots, tools and best practices: 3 must-reads

Read Now